Fmoc-O-benzyl-L-threonine

Fmoc-O-benzyl-L-threonine is an Fmoc-protected L-threonine derivative in which the threonine side-chain hydroxyl is masked as a benzyl ether, retaining the stereogenic center at the α-carbon while providing orthogonal functional-group protection for peptide chemistry. The molecule contains a carbamate-forming Fmoc group on the amino functionality, a free carboxylate equivalent suitable for coupling after activation, and a benzyl-protected alcohol that can be selectively removed under hydrogenolysis conditions. The combination of an acid-labile/photolabile Fmoc protecting group and a hydrogenolysis-removable O-benzyl group supports controlled deprotection sequences and minimizes side reactions during chain assembly. The resulting chiral amino acid building block participates in standard peptide coupling chemistry and serves as a stereochemically defined intermediate for threonine-containing peptides and threonine-derived functional motifs.

1. Peptide Synthesis

Fmoc-O-benzyl-L-threonine is applied in solid-phase peptide synthesis and solution-phase peptide coupling where threonine incorporation requires orthogonal protection of both the amino and side-chain hydroxyl. The Fmoc carbamate enables iterative N-terminal deprotection and re-coupling, while the O-benzyl ether protects the β-hydroxyl from esterification or undesired crosslinking during peptide assembly. The chiral α-center supports stereochemically consistent threonine residues in the growing peptide chain, and the carboxyl functionality can be activated to form amide bonds with incoming amino components. Downstream deprotection can reveal the free threonine side-chain alcohol for subsequent modifications, including phosphorylation-mimetic derivatization or conjugation handles, making the compound suitable for peptide building block preparation in biochemical research and fine chemical synthesis.

2. Protected Amino Acids

Fmoc-O-benzyl-L-threonine is used as a protected amino acid intermediate for manufacturing workflows that require predictable protection group behavior and controlled deprotection logic. The Fmoc group provides a robust N-protection strategy compatible with common peptide coupling reagents, whereas the benzyl ether on the side-chain hydroxyl supports orthogonal removal without disturbing the N-protecting group during earlier steps. The protected alcohol reduces polarity and suppresses side reactions such as intramolecular cyclization or uncontrolled ester formation, which can be relevant when scaling chiral amino acid derivative synthesis and purification. The compound can be employed to generate threonine-containing peptide segments, chiral fragments for peptidomimetic construction, and process chemistry intermediates that rely on stereochemical integrity and selective functional-group unveiling.

3. Side-Chain Functionalization

Fmoc-O-benzyl-L-threonine is applied in chemical biology and medicinal chemistry research to access threonine side-chain alcohol functionality after controlled deprotection. The benzyl-protected hydroxyl serves as a protected handle that can be revealed to enable subsequent derivatization into esters, ethers, or phosphoryl analogs that mimic post-translational modification motifs. The presence of a defined threonine stereocenter supports consistent spatial presentation of the hydroxyl group in peptide analogs and structure-activity relationship studies. The resulting functionalized derivatives can be used as molecular probes, peptidomimetic fragments, or conjugation-ready intermediates for downstream assembly into larger biomolecule constructs.

4. Bioconjugation Chemistry

Fmoc-O-benzyl-L-threonine is relevant to bioconjugation workflows where threonine-derived hydroxyl groups are introduced into peptide linkers and then converted into conjugation-compatible motifs. The protected amino acid form supports stepwise synthesis of peptide tags with controlled N-terminus handling via Fmoc chemistry, while the O-benzyl ether allows the hydroxyl to remain masked until conjugation-ready stages. After deprotection, the free side-chain alcohol can participate in selective functional group transformations that generate stable linkages for attaching biomolecules or surfaces. The chiral, threonine-based linker architecture can improve reproducibility in labeling strategies and supports the preparation of defined conjugates for analytical research and applied biochemical studies.

5. Pharmaceutical Manufacturing

Fmoc-O-benzyl-L-threonine can be employed in pharmaceutical intermediate preparation where threonine-containing peptide segments are manufactured with protection schemes that align with robust coupling and purification operations. The Fmoc-protected amine supports controlled N-terminal activation and minimizes side reactions during assembly of peptide intermediates, while the benzyl ether on the side-chain hydroxyl provides a stable protection state during manufacturing steps. The amino acid's defined stereochemistry helps ensure consistent structural fidelity across peptide batches, which is critical for downstream quality of peptide-based active ingredients or process intermediates. The compound's compatibility with standard peptide coupling chemistry makes it suitable for scaling chiral building block synthesis and for producing protected peptide fragments that can later undergo deprotection and functionalization to meet specific manufacturing route requirements.

6. Analytical Research Standards

Fmoc-O-benzyl-L-threonine is utilized in analytical research as a structurally defined threonine building block for method development and reference material preparation in peptide analysis. The Fmoc and benzyl protections create a predictable mass and chromatographic behavior that can support calibration or identification of threonine-containing fragments during LC-MS and related workflows. The orthogonal deprotection potential enables generation of controlled derivatives, such as threonine side-chain-unmasked forms, for verifying derivatization specificity and monitoring conversion states. The compound thereby functions as a chiral amino acid intermediate for analytical method validation, impurity profiling, and characterization of peptide coupling or deprotection processes in applied chemical manufacturing and biochemical research environments.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes